Robert H. Collins

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea et al. · Blood · 2017 · 1.5K citations · Full text

Medicine, Hematology, Oncology +13

Functional genomic landscape of acute myeloid leukaemia

Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly et al. · Nature · 2018 · 1.5K citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

Robert H. Collins, Ofer Shpilberg, William R. Drobyski et al. · Journal of Clinical Oncology · 1997 · 1.3K citations

Medicine, Hematology, Immunology +8

Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution

Daniel C. Douek, Robert Vescio, Michael R. Betts et al. · The Lancet · 2000 · 577 citations

Life Sciences, Hematology, Immunology +16